search:
			October 25, 2005 (Long Beach, CA) – Obagi Medical Products, Inc. (Obagi) a leader in specialty skin health products, announced today that its Board of Directors has named Steven R. Carlson as the Company’s President and CEO. Carlson, who joined the Company in March 2005 as the President, brings a 25 year record of building successful pharmaceutical companies, leading brands and creating new products. In this expanded role, he will work closely with Austin McNamara, who will continue as Chairman of the Board of Directors. “Steve joined Obagi Medical Products at a critical stage in our development. He has brought a unique combination of outstanding strategic thinking, exceptional senior management skills, and deep industry experience, particularly for bringing new product technologies to market,” said McNamara. “Steve’s rapid demonstration and success in accelerating our new product development efforts and establishing strategic corporate alliances, led to our decision to expand Steve’s responsibilities to President and Chief Executive Officer.” “Obagi Medical Products is uniquely positioned as the leading direct-to-physician company providing physicians and their patients with proprietary, clinically proven, therapeutic systems which truly make a difference in patient’s lives” commented Carlson. “I look forward to building on the company’s superior product technologies.” Carlson began his career with 15 years at Allergan, where his management experience included Senior Vice President of Marketing and General Manager for the Botox Global business, building the first $100 million of revenue under the Botox brand. More recently, Carlson has held senior executive positions with successful start-up ventures including ReVance Therapeutics (formerly Essentia Biosystems), and Orquest Inc. (acquired by Johnson and Johnson). His experience includes a broad number of medical industries such as Dermatology, Plastic Surgery, Orthopedics and Neurology. Carlson received his MBA from Pepperdine University and has a BS in Biology and Chemistry from the University of Minnesota With the promotion of Carlson, Obagi Medical Products also announces two additional key management promotions: Curtis A. Cluff has been promoted to the position of Executive Vice President of Corporate Development and Operations. His responsibilities will include all international sales and marketing activities, in addition to developing strategic relationships. Cluff joined Obagi in January 2002 as Chief Financial Officer, and has 14 years of experience including senior management roles in operations and finance. He gained a deep understanding of market development and distribution while serving as the senior financial officer for Merisel Inc, then a $5 billion technology distribution giant. Stephen A. Garcia has been promoted to Chief Financial Officer. Garcia’s responsibilities will include all finance, accounting and information technology activities. Having joined Obagi in July 2003, Garcia has been serving as the Company’s Vice President of Finance. He brings extensive financial and accounting expertise, with 15 years of senior management roles in Finance and IT. Prior to joining Obagi, he served in senior finance roles, including 5 years as CFO for Incomnet Communications and CCC Global Com. Garcia maintains his CPA credential, and began his career in audit and advisory services with Deloitte & Touche, LLP. “This is an exciting time in our industry, and we now have an exceptional team in place” said McNamara. “These promotions reflect the talent and accomplishments of these individuals, and will provide greater management focus on the company’s strategic growth, technology development and partnering initiatives.” For more information, contact Rpr at 212-317-1462. About Obagi Medical Products, Inc. Obagi is a specialty pharmaceutical company that develops and commercializes innovative skin health products for the dermatology, plastic surgery, and related Aesthetic and Therapeutic markets. Obagi’s product systems are uniquely designed to improve penetration of drug agents across the skin barrier for the prevention and correction of the most common and visible skin disorders in adult skin such as chloasma, melasma, senile lentigines, acne vulgaris and sun damage. Obagi System products are only available through physicians, which include over 3,500 in the U.S., primarily Dermatologists, Plastic Surgeons, Medical Spas and other Skin Care Specialists. Obagi also works with 11 distributors, who support 37 countries globally.